Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1943 2
1947 1
1950 1
1951 1
1952 1
1953 1
1955 1
1957 1
1958 3
1960 1
1961 2
1964 4
1965 2
1966 2
1967 1
1968 3
1969 1
1970 1
1971 7
1972 10
1973 3
1974 5
1975 7
1976 8
1977 8
1978 13
1979 13
1980 15
1981 15
1982 12
1983 19
1984 26
1985 19
1986 26
1987 35
1988 28
1989 24
1990 29
1991 27
1992 25
1993 24
1994 17
1995 30
1996 26
1997 22
1998 29
1999 32
2000 31
2001 41
2002 24
2003 30
2004 37
2005 34
2006 35
2007 35
2008 39
2009 46
2010 41
2011 43
2012 55
2013 48
2014 40
2015 47
2016 43
2017 36
2018 41
2019 31
2020 51
2021 35
Text availability
Article attribute
Article type
Publication date

Search Results

1,358 results
Results by year
Filters applied: . Clear all
Page 1
Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer.
Overman MJ, Lonardi S, Wong KYM, Lenz HJ, Gelsomino F, Aglietta M, Morse MA, Van Cutsem E, McDermott R, Hill A, Sawyer MB, Hendlisz A, Neyns B, Svrcek M, Moss RA, Ledeine JM, Cao ZA, Kamble S, Kopetz S, André T. Overman MJ, et al. Among authors: moss ra. J Clin Oncol. 2018 Mar 10;36(8):773-779. doi: 10.1200/JCO.2017.76.9901. Epub 2018 Jan 20. J Clin Oncol. 2018. PMID: 29355075 Free article.
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Overman MJ, McDermott R, Leach JL, Lonardi S, Lenz HJ, Morse MA, Desai J, Hill A, Axelson M, Moss RA, Goldberg MV, Cao ZA, Ledeine JM, Maglinte GA, Kopetz S, André T. Overman MJ, et al. Among authors: moss ra. Lancet Oncol. 2017 Sep;18(9):1182-1191. doi: 10.1016/S1470-2045(17)30422-9. Epub 2017 Jul 19. Lancet Oncol. 2017. PMID: 28734759 Free PMC article. Clinical Trial.
A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS; VX08-770-102 Study Group. Ramsey BW, et al. Among authors: moss r. N Engl J Med. 2011 Nov 3;365(18):1663-72. doi: 10.1056/NEJMoa1105185. N Engl J Med. 2011. PMID: 22047557 Free PMC article. Clinical Trial.
Procurement.
Moss RJ, Batista A, Makridaki D, Süle A, Kohl S. Moss RJ, et al. Eur J Hosp Pharm. 2019 May;26(3):173-174. doi: 10.1136/ejhpharm-2018-001822. Epub 2019 May 7. Eur J Hosp Pharm. 2019. PMID: 31428327 Free PMC article. Review.
eHealth and mHealth.
Moss RJ, Süle A, Kohl S. Moss RJ, et al. Eur J Hosp Pharm. 2019 Jan;26(1):57-58. doi: 10.1136/ejhpharm-2018-001819. Epub 2018 Dec 21. Eur J Hosp Pharm. 2019. PMID: 31157099 Free PMC article.
Neoadjuvant Therapy for Melanoma: A U.S. Food and Drug Administration-Melanoma Research Alliance Public Workshop.
Mueller KL, Theoret MR, Lemery SJ, Amiri-Kordestani L, Ariyan CE, Atkins MB, Berry DA, Blank CU, DeMichele AM, Forde PM, Ibrahim N, Keegan P, Mitchell TC, Moss RA, Robert C, Sridhara R, Taube JM, Tetzlaff MT, Wargo JA, Flaherty KT, Kaplan MJ, Topalian SL, Ward AF, Hurlbert MS. Mueller KL, et al. Among authors: moss ra. Clin Cancer Res. 2021 Jan 15;27(2):394-401. doi: 10.1158/1078-0432.CCR-20-3285. Epub 2020 Nov 13. Clin Cancer Res. 2021. PMID: 33188142 Free article. Review.
1,358 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page